Article
A bioengineered immunocompetent human leukemia chip for preclinical screening of CAR T cell immunotherapy
2023-04-21
Abstract excerpt
<title>Abstract</title> <p>Chimeric antigen receptor (CAR) T cell immunotherapy is promising for treatment of blood cancers; however, clinical benefits remain unpredictable, necessitating development of optimal CAR T cell products. Unfortunately, current preclinical evaluation platforms are inadequate due to their limited physiological relevance to humans. We herein engineered an organotypic immunocompetent chip...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b6ac7f5b-8702-5236-b9c5-11f46e51299b
- DOI
- 10.21203/rs.3.rs-2762929/v1
